Andrew Koopman joins RHI with more than 30 years in the Biotechnology and Biomedical industries. He is currently a business development consultant and strategic advisor, working with universities, investors, biotechnology/biomedical startups, and incubators. He is also a member of the Board of Directors for PainQx, Inc., an officer in Applied Glycan Technologies, Inc., and an NIH SBIR mentor. Prior to consulting, Mr. Koopman was CEO and President of Zero Gravity Life Sciences where he was responsible for the development and execution of the strategic business plan, intellectual property and grant strategies, and management of the scientific team. From 2006 to 2016, he was Director of New Ventures at New York University where he launched and built startup companies based upon NYU’s life science technologies. Prior to that, he served as a Managing Director at Beroff Associates, a boutique merchant investment bank, after a decade in the pharmaceutical industry. Throughout his career, Koopman has gained extensive industry knowledge and experience in Life Sciences, Pharmaceuticals, Product Development, Business Development, Entrepreneurship, Corporate Strategy, Research and Development, Medical Devices, Licensing, and more.